Long-acting reversible contraception by effervescent microneedle patch

Sci Adv. 2019 Nov 6;5(11):eaaw8145. doi: 10.1126/sciadv.aaw8145. eCollection 2019 Nov.

Abstract

To increase access to long-acting contraception, we developed a reversible contraceptive microneedle patch that is simple-to-administer, slowly releases contraceptive hormone (levonorgestrel) for >1 month, and generates no biohazardous sharps waste. After manually pressing the patch to skin for 1 min, microneedles rapidly separate from the patch within the skin due to effervescence triggered by contact with skin's interstitial fluid, as demonstrated in rats and human participants. Long-acting contraception is achieved by formulating microneedles with a biodegradable polymer [poly(lactic-co-glycolic) acid] that slowly releases levonorgestrel for ~1 month in vitro. In rats, the patch maintained levonorgestrel concentration above the human contraceptive threshold level for >1 month, and a placebo microneedle patch was well-tolerated in human participants. Women of reproductive age in three continents demonstrated interest in and preference for long-acting contraception by microneedle patch. These studies indicate that an effervescent microneedle patch could facilitate greater access to long-acting contraception.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Animals
  • Contraceptive Agents, Female / administration & dosage
  • Drug Delivery Systems / methods*
  • Female
  • Humans
  • Levonorgestrel / administration & dosage*
  • Long-Acting Reversible Contraception / instrumentation*
  • Long-Acting Reversible Contraception / methods*
  • Rats, Sprague-Dawley
  • Reproducibility of Results
  • Young Adult

Substances

  • Contraceptive Agents, Female
  • Levonorgestrel